© 1997 by European Society of Cardiology
Copyright © 1997, European Society of Cardiology
Homocysteine induces synthesis of a serine elastase in arterial smooth muscle cells from multi-organ donors
aINSERM CJF 9401, Laboratory of Biochemistry, School of Pharmacy, Marseilles, France
bVascular Surgery Department, Sainte Marguerite Hospital, Marseilles, France
* Corresponding author. Laboratoire de Biochimie, Faculté de Pharmacie, 27 bld Jean Moulin, 13385 Marseille cedex 05, France. Tel.: +33 9183 5672; fax: +33 9125 4720.
Objectives: In heart transplant recipients with diffuse coronary arteriopathy, we have previously demonstrated the prevalence of elevated homocysteinemia, also known as an independent risk factor for myocardial infarction and stroke. In hyperhomocysteinemic mini-pigs we also observed early detectable pathologic changes in the elastic laminae. We hypothesized that homocysteine causes premature breakdown in the arterial elastic fibers by activation of the elastolytic activities. Methods: We examined the effect of homocysteine on elastase-like production by smooth muscle cells from sub-inguinal arteries of multi-organ donors (23.4±3.4 yr, n=8). The freshly isolated cells were incubated for 0–72 h with homocysteine (0–250 µM), in the presence or absence of specific protease inhibitors. Results: Homocysteine was devoid of a direct effect, but after 18 h incubation the elastase-like activities increased by 5–6-fold in the extracellular medium. The enzymes were characterized as serine proteases. Incubation of cells with a nucleic acid synthesis inhibitor (actinomycin D) or a protein synthesis inhibitor (cycloheximide) suppressed the enzyme induction. Conclusions: This is the first report of serine protease induction by homocysteine in vascular smooth muscle cells. The process may require protein synthesis and account for the early alterations of the arterial elastic structures in heart transplant recipients, and in other hyperhomocysteinemic patients, as well.
KEYWORDS Hcys = homocysteine; VSMC = vascular smooth muscle cells; SANA = N-succinyl trialanylnitroanilide; NMSN = N-methoxysuccinyl-Ala–Ala–Pro–Val-nitroanilide
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
B. Granel, P. Rossi, L. Bonello, D. Brunet, F. Bernard, and Y. Frances Coronary artery dissection in adult-onset homocystinuria BMJ Case Reports, September 2, 2009; 2009(sep02_1): bcr0620091990 - bcr0620091990. [Abstract] [Full Text] |
||||
![]() |
B Giusti, C Saracini, P Bolli, A Magi, I Sestini, E Sticchi, G Pratesi, R Pulli, C Pratesi, and R Abbate Genetic analysis of 56 polymorphisms in 17 genes involved in methionine metabolism in patients with abdominal aortic aneurysm J. Med. Genet., November 1, 2008; 45(11): 721 - 730. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Rubinstein, S. M. Peerdeman, M. W. van Tulder, I. Riphagen, and S. Haldeman A Systematic Review of the Risk Factors for Cervical Artery Dissection Stroke, July 1, 2005; 36(7): 1575 - 1580. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Giusti, M. C. Porciani, T. Brunelli, L. Evangelisti, S. Fedi, G. F. Gensini, R. Abbate, G. Sani, M. Yacoub, and G. Pepe Phenotypic variability of cardiovascular manifestations in Marfan Syndrome: Possible role of hyperhomocysteinemia and C677T MTHFR gene polymorphism Eur. Heart J., November 2, 2003; 24(22): 2038 - 2045. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Caso and V. Gallai Why Should Mild Hyperhomocysteinemia Be Responsible for CAD? Stroke, November 1, 2003; 34 (11): e209 - e209. [Full Text] [PDF] |
||||
![]() |
A. Pezzini, E. Del Zotto, S. Archetti, R. Negrini, P. Bani, A. Albertini, M. Grassi, D. Assanelli, R. Gasparotti, L. A. Vignolo, et al. Plasma Homocysteine Concentration, C677T MTHFR Genotype, and 844ins68bp CBS Genotype in Young Adults With Spontaneous Cervical Artery Dissection and Atherothrombotic Stroke Stroke, March 1, 2002; 33(3): 664 - 669. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Y. Jeremy, D. Rowe, A. M. Emsley, and A. C. Newby Nitric oxide and the proliferation of vascular smooth muscle cells Cardiovasc Res, August 15, 1999; 43(3): 580 - 594. [Full Text] [PDF] |
||||




